今开:0.4865 | 昨收:0.493 |
最高:0.5055 | 最低:0.46001 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.04370291E8 |
Sangamo Therapeutics(SGMO)02-13 08:15
$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-032402 Act: 34 Size: 41 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)02-28 06:15
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005549 Size: 9 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)04-06 04:05
$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000068 Act: 34 Size: 4 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)04-20 04:25
$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893 Act: 34 Size: 17 MB 网页链接查看全文
Sangamo Therapeutics(SGMO)02-28 06:15
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005550 Size: 9 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)02-28 06:15
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005548 Size: 9 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)04-04 05:25
$Sangamo Therapeutics(SGMO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001628280-24-014660 Act: 34 Size: 17 MB 网页链接查看全文
Sangamo Therapeutics(SGMO)02-07 05:45
$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-24-003506 Act: 34 Size: 5 MB 网页链接查看全文
Sangamo Therapeutics(SGMO)02-10 01:25
$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000014 Act: 34 Size: 4 KB 网页链接查看全文
Sangamo Therapeutics(SGMO)03-13 20:05
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-010790 Act: 34 Size: 360 KB 网页链接查看全文
智通财经APP获悉,近期,RBC针对Verrica Pharmaceuticals(VRCA.US)、Sangamo Therapeutics(SGMO.US)、GooseHead Insurance(GSHD.US)三家公司发表研报,并强调了这三只股票未来强劲的长期增长前景,预计在未来一年的上行空间将至少达到50... 网页链接
$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893 Act: 34 Size: 17 MB 网页链接
$Sangamo Therapeutics(SGMO)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-016932 Act: 34 Size: 17 MB 网页链接
$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000068 Act: 34 Size: 4 KB 网页链接
$Sangamo Therapeutics(SGMO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001628280-24-014660 Act: 34 Size: 17 MB 网页链接
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-076613 Act: 34 Size: 915 KB 网页链接
$Sangamo Therapeutics(SGMO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-076462 Act: 33 Size: 3 MB 网页链接
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-010790 Act: 34 Size: 360 KB 网页链接
$Sangamo Therapeutics(SGMO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-010788 Act: 34 Size: 42 MB 网页链接
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005552 Size: 9 KB 网页链接
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005546 Size: 9 KB 网页链接